Pioglitazone Cuts Diabetes Risk After Ischemic Stroke, TIA

Share this content:
Pioglitazone Cuts Diabetes Risk After Ischemic Stroke, TIA
Pioglitazone Cuts Diabetes Risk After Ischemic Stroke, TIA

FRIDAY, Aug. 5, 2016 (HealthDay News) -- For insulin-resistant patients with recent ischemic stroke or transient ischemic attack, pioglitazone is associated with reduced risk of diabetes, according to a study published online July 27 in Diabetes Care.

Silvio E. Inzucchi, M.D., from the Yale School of Medicine in New Haven, Conn., and colleagues examined the metabolic effects of pioglitazone and diabetes prevention in a trial involving 3,876 patients with recent ischemic stroke or transient ischemic attack, no history of diabetes, fasting plasma glucose (FPG) <126 mg/dL, and insulin resistance by homeostasis model assessment of insulin resistance (HOMA-IR) score >3.0. Participants were randomized to receive pioglitazone or placebo.

The researchers found that the mean HOMA-IR and FPG decreased in the pioglitazone group and increased in the placebo group (all P < 0.0001) after one year. Diabetes developed in 3.8 and 7.7 percent of participants in the pioglitazone and placebo groups, respectively, over a median follow-up of 4.8 years (hazard ratio, 0.48). This effect was mainly driven by those with initial impaired fasting glucose or elevated hemoglobin A1c (hazard ratios, 0.41 and 0.46, respectively).

"Pioglitazone is the first medication shown to prevent both progression to diabetes and major cardiovascular events as prespecified outcomes in a single trial," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Takeda Pharmaceuticals, which provided pioglitazone and placebo.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Both Statin, Non-Statin Therapies Effective for Lowering LDL

Both Statin, Non-Statin Therapies Effective for Lowering LDL

Dietary changes, other meds, and even surgery can lower cardiovascular risk similarly to statins

Negative Effects Seen With Video Gaming 9 Hours/Week

Negative Effects Seen With Video Gaming 9&#43; Hours/Week

Benefits seen with one hour a week, but behavioral problems appear to rise at nine hours a week

Improved Adult Lung Function Linked to Childhood Farm Life

Improved Adult Lung Function Linked to Childhood Farm ...

First study to report beneficial effects of growing up on a farm on adult FEV1

is free, fast, and customized just for you!

Already a member?

Sign In Now »